TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry. This new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting safety and efficacy standards.

The US Department of Agriculture last week issued a conditional license for an avian flu vaccine for use in chickens, as an outbreak of a newer variant ravages poultry flocks, contributing to the sky high price of eggs.

In the past three years, the U.S. Department of Agriculture (USDA) says about 150 million birds died across the country due to the virus. This month, the USDA granted a conditional license to Zoetis for its Avian Influenza Vaccine.

The Government of Canada has secured an initial supply of 500,000 doses of GSK's bird flu vaccine to protect individuals most at risk of being exposed to the virus through animals infected with avian influenza.

Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 million birds have been affected in the US, causing egg prices to surge to all-time highs.

In a bid to contain a bird flu outbreak that has sent egg prices soaring, the U.S. Department of Agriculture (USDA) last week granted a conditional license for a vaccine designed to protect chickens from the virus.

As bird flu cases continue to pop up in humans, Canada announced Wednesday that it purchased 500,000 doses of vaccine targeted at the virus. Here’s what you need to know about bird flu vaccinations in the U.